Leukemia, Myelodysplasia, Transplantation
News
Second-line CML drugs prove better than first
Nilotinib and dasatinib, currently approved for the treatment of drug-resistant chronic myeloid leukemia (CML), provide quicker and better...
News
ODAC votes against one leukemia, one NHL drug
Video
CML Treatment: Old Drug, New Name
News
Fostamatinib successfully targets the B-cell receptor
The B-cell receptor is present on both normal B cells and malignant B cells. Signaling through this receptor is necessary for B-cell maturation...
News
Agent shows promise in acute leukemias
Delivering drugs in combination requires a certain balance, a balance that ensures the drugs act synergistically. And researchers say they have...
News
Ofatumumab receives accelerated approval from FDA
The drug was approved under the FDA’s accelerated approval process, which allows drugs that meet unmet medical needs to be approved faster.
News
Survival improves for AYAs with leukemia and lymphoma
However, their survival still lags behind survival in children.